KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Operating Leases (2019 - 2025)

Historic Operating Leases for Fulgent Genetics (FLGT) over the last 6 years, with Q3 2025 value amounting to $3.6 million.

  • Fulgent Genetics' Operating Leases fell 2230.8% to $3.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 million, marking a year-over-year decrease of 2230.8%. This contributed to the annual value of $4.1 million for FY2024, which is 4235.34% down from last year.
  • Latest data reveals that Fulgent Genetics reported Operating Leases of $3.6 million as of Q3 2025, which was down 2230.8% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Fulgent Genetics' Operating Leases registered a high of $8.8 million during Q4 2022, and its lowest value of $3.6 million during Q3 2025.
  • Moreover, its 4-year median value for Operating Leases was $4.7 million (2024), whereas its average is $5.5 million.
  • As far as peak fluctuations go, Fulgent Genetics' Operating Leases crashed by 1873.79% in 2023, and later crashed by 4737.95% in 2025.
  • Over the past 4 years, Fulgent Genetics' Operating Leases (Quarter) stood at $8.8 million in 2022, then dropped by 18.74% to $7.1 million in 2023, then tumbled by 42.35% to $4.1 million in 2024, then fell by 12.09% to $3.6 million in 2025.
  • Its Operating Leases stands at $3.6 million for Q3 2025, versus $3.8 million for Q2 2025 and $3.9 million for Q1 2025.